{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glanzmann-thrombasthenia-2","columns":[{"gene":"","key":"population-499daf6a0c0ab9c249cb","label":"Glanzmann thrombasthenia 2","mondoId":"MONDO:0031009","onsetQualifier":null,"originColumnKey":"MONDO:0031009/OMIM:619267","originalViews":[{"key":"MONDO:0031009/OMIM:619267","label":"Glanzmann thrombasthenia 2","scopeLabel":"OMIM:619267","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["04fafe3f5076e9a4af8fccce0d22acfc1299904f7fdfca36e92709a634c5ba4f","1474d2417c980093feca6b5d014ea063975cdc468a8ed427dd51d21008a6fef1","1c687186df7fa088843bee62ec7fb4a07f5085ae2694a924d9910e8ba309ddd0","21b8b42bb81cb2c61b7aad9a041b8a47057248c83cd820d046962132a43020f0","40f8dd6dc884290dbb22aebb073d370acd4cf2669e7a8e06e7687782011d95d2","75a3a263604eeb457d6897cca3f850686c76d0de59aff123660e61be4314af6f","7dee85bc598eaa8fcb7a87460cab8d0aa071587cecf75d3ce0f27ddfbb7e9858","8a0e4030c7bd042193cb9ab698eaeaadf129653b5a77c4ee69191c1f75268cdc","a9568673372c93335897397f11a30d22d5b311b072e2cfab2c1226cad5318939","aa64774197797f539d11e17309abfa9090cf94febf82eac509348935eaa9e639","bfe25a0da5c7f8cc37d9525909377018b07ccf086e123930a43c2fc818b40c0f","c0bad1cff076b8c83f48a564fbea884ceafb6d64608678533095ecaa7bf74fd6","f7f4075e0aaadd04aff4c009ac9fc0a51be4ab10b90ac70e9ebbf31ef3585b96"],"recordQualifiers":{},"scopeLabel":"OMIM:619267","sourceIds":["OMIM:619267"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-499daf6a0c0ab9c249cb"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001892","HP:0000978","HP:0001975","HP:0000421","HP:0004866","HP:0031126","HP:0008320"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":9,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":13,"sourceGroups":{"published":13}},"features":[{"hpoId":"HP:0001892","label":"Abnormal bleeding","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0001975","label":"Decreased platelet glycoprotein IIb-IIIa","primary":true},{"hpoId":"HP:0000421","label":"Epistaxis","primary":true},{"hpoId":"HP:0004866","label":"Impaired ADP-induced platelet aggregation","primary":true},{"hpoId":"HP:0031126","label":"Impaired clot retraction","primary":true},{"hpoId":"HP:0008320","label":"Impaired collagen-induced platelet aggregation","primary":true},{"hpoId":"HP:0008148","label":"Impaired epinephrine-induced platelet aggregation","primary":false},{"hpoId":"HP:0011871","label":"Impaired ristocetin-induced platelet aggregation","primary":false},{"hpoId":"HP:0000132","label":"Menorrhagia","primary":false},{"hpoId":"HP:0006298","label":"Prolonged bleeding after dental extraction","primary":false},{"hpoId":"HP:0004846","label":"Prolonged bleeding after surgery","primary":false},{"hpoId":"HP:0003010","label":"Prolonged bleeding time","primary":false}],"ledeHtml":"A platelet type bleeding disorder characterized by lifelong mucocutaneous bleeding, severely impaired platelet aggregation, and absent or markedly reduced clot retraction due to loss of αIIbβ3‑mediated fibrinogen binding. Platelet number and morphology are typically normal, but responses to physiologic agonists, such as ADP, collagen, epinephrine, and thrombin are severely diminished or absent, while ristocetin‑induced agglutination is preserved. Biallelic loss‑of‑function ITGB3 variants result in reduced or absent β3 integrin production, preventing assembly or surface expression of the αIIbβ3 receptor complex and producing the characteristic Glanzmann thrombasthenia phenotype.","mondoId":"MONDO:0031009","node":{"canonicalSlug":"glanzmann-thrombasthenia-2","comparisons":[{"documentSha256":"5d6473eece949923903a91364bcef79cec9565238c5f74ddb88603172293a6bf","key":"legacy-glanzmann-thrombasthenia","kind":"legacy","label":"Glanzmann thrombasthenia","memberIds":["MONDO:0031009","MONDO:0031332","MONDO:0100326"],"mondoId":"MONDO:0100326","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/glanzmann-thrombasthenia.5d6473eece949923903a91364bcef79cec9565238c5f74ddb88603172293a6bf.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Glanzmann thrombasthenia 2","paragraphs":["A platelet type bleeding disorder characterized by lifelong mucocutaneous bleeding, severely impaired platelet aggregation, and absent or markedly reduced clot retraction due to loss of αIIbβ3‑mediated fibrinogen binding. Platelet number and morphology are typically normal, but responses to physiologic agonists, such as ADP, collagen, epinephrine, and thrombin are severely diminished or absent, while ristocetin‑induced agglutination is preserved. Biallelic loss‑of‑function ITGB3 variants result in reduced or absent β3 integrin production, preventing assembly or surface expression of the αIIbβ3 receptor complex and producing the characteristic Glanzmann thrombasthenia phenotype."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40028/, https://orcid.org/0000-0002-7437-8060, PMID:20020534, PMID:2014236, PMID:9845537","url":"https://monarchinitiative.org/MONDO:0031009"},"ownColumnKeys":["population-499daf6a0c0ab9c249cb"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive disease","mondoId":"MONDO:0006025","slug":null},{"kind":"parent","label":"Glanzmann thrombasthenia","mondoId":"MONDO:0100326","slug":"glanzmann-thrombasthenia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/16439"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"04fafe3f5076e9a4af8fccce0d22acfc1299904f7fdfca36e92709a634c5ba4f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"35/37","hpo_id":"HP:0031126","is_excluded":false,"label":"Impaired clot retraction","onset_id":null,"reference":"PMID:16463284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1474d2417c980093feca6b5d014ea063975cdc468a8ed427dd51d21008a6fef1","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"0/40","hpo_id":"HP:0011871","is_excluded":true,"label":"Impaired ristocetin-induced platelet aggregation","onset_id":null,"reference":"PMID:16463284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1c687186df7fa088843bee62ec7fb4a07f5085ae2694a924d9910e8ba309ddd0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"PMID:21917754;PMID:9845537","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"21b8b42bb81cb2c61b7aad9a041b8a47057248c83cd820d046962132a43020f0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"21/27","hpo_id":"HP:0001975","is_excluded":false,"label":"Decreased platelet glycoprotein IIb-IIIa","onset_id":null,"reference":"PMID:20020534;PMID:2014236","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"40f8dd6dc884290dbb22aebb073d370acd4cf2669e7a8e06e7687782011d95d2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"PMID:9845537","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"75a3a263604eeb457d6897cca3f850686c76d0de59aff123660e61be4314af6f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0000132","is_excluded":false,"label":"Menorrhagia","onset_id":null,"reference":"PMID:21917754;PMID:9845537","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7dee85bc598eaa8fcb7a87460cab8d0aa071587cecf75d3ce0f27ddfbb7e9858","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"PMID:21917754","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8a0e4030c7bd042193cb9ab698eaeaadf129653b5a77c4ee69191c1f75268cdc","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"40/40","hpo_id":"HP:0004866","is_excluded":false,"label":"Impaired ADP-induced platelet aggregation","onset_id":null,"reference":"PMID:16463284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a9568673372c93335897397f11a30d22d5b311b072e2cfab2c1226cad5318939","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004846","is_excluded":false,"label":"Prolonged bleeding after surgery","onset_id":null,"reference":"PMID:21917754","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aa64774197797f539d11e17309abfa9090cf94febf82eac509348935eaa9e639","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"40/40","hpo_id":"HP:0008320","is_excluded":false,"label":"Impaired collagen-induced platelet aggregation","onset_id":null,"reference":"PMID:16463284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bfe25a0da5c7f8cc37d9525909377018b07ccf086e123930a43c2fc818b40c0f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003010","is_excluded":false,"label":"Prolonged bleeding time","onset_id":null,"reference":"PMID:20020534","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c0bad1cff076b8c83f48a564fbea884ceafb6d64608678533095ecaa7bf74fd6","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":"40/40","hpo_id":"HP:0008148","is_excluded":false,"label":"Impaired epinephrine-induced platelet aggregation","onset_id":null,"reference":"PMID:16463284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f7f4075e0aaadd04aff4c009ac9fc0a51be4ab10b90ac70e9ebbf31ef3585b96","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619267","disease_name":"Glanzmann thrombasthenia 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0006298","is_excluded":false,"label":"Prolonged bleeding after dental extraction","onset_id":null,"reference":"PMID:21917754","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0031009\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40028/, https://orcid.org/0000-0002-7437-8060, PMID:20020534, PMID:2014236, PMID:9845537</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A platelet type bleeding disorder characterized by lifelong mucocutaneous bleeding, severely impaired platelet aggregation, and absent or markedly reduced clot retraction due to loss of αIIbβ3‑mediated fibrinogen binding. Platelet number and morphology are typically normal, but responses to physiologic agonists, such as ADP, collagen, epinephrine, and thrombin are severely diminished or absent, while ristocetin‑induced agglutination is preserved. Biallelic loss‑of‑function ITGB3 variants result in reduced or absent β3 integrin production, preventing assembly or surface expression of the αIIbβ3 receptor complex and producing the characteristic Glanzmann thrombasthenia phenotype.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0031009\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"glanzmann-thrombasthenia-2","sourceDocuments":[{"name":"MONDO: Glanzmann thrombasthenia 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0031009"}],"sourceNote":"","synonyms":["bleeding disorder, platelet-type, 23","Glanzmann thrombasthenia 2","GT2","ITGB3-related Glanzmann thrombasthenia"],"takeawayHtml":"","title":"Glanzmann thrombasthenia 2"},"schemaVersion":1}
